|
|
|
|
|
|
|
Aeterna Zentaris (AEZS)
|
|
1.56 0.06 (4%)
|
04-20 15:59
|
|
Open:
|
1.5
|
Pre. Close:
|
1.5
|
|
High:
|
1.5982
|
Low:
|
1.481
|
|
Volume:
|
33,100
|
Market Cap:
|
24M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.602 - 1.608
|
1.608 - 1.614
|
|
Low:
|
1.465 - 1.472
|
1.472 - 1.479
|
|
Close:
|
1.548 - 1.559
|
1.559 - 1.571
|
|
|
|
Technical analysis (as of: 2018-04-20 4:27:14 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 2.01 One year: 2.35
|
|
Support:
|
Support1: 1.35 Support2: 1.12
|
|
Resistance:
|
Resistance1:
1.72 Resistance2: 2.01
|
|
Pivot:
|
1.38 
|
|
Moving Averages:
|
MA(5): 1.49 MA(20): 1.42 
MA(100): 1.93 MA(250): 1.77
|
|
MACD:
|
MACD(12,26):
-0.04 Signal(12,26,9): -0.08
|
|
%K %D:
|
%K(14,3): 82.77 %D(3): 72.50
|
|
RSI:
|
RSI(14): 54.22
|
|
52-Week:
|
High: 3.75
Low: 0.78 Change(%): -48.9
|
|
Average Vol(K):
|
3-Month: 13925
10-Days 7027
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.AEZS has closed below upper band by 4.7%. Bollinger Bands are 9.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-03-28T12:25:45-04:00
Aeterna Zentaris' (AEZS) CEO Michael Ward on Q4 2017 Results - Earnings Call Transcript
2018-03-28T07:06:18-04:00
AEterna Zentaris beats by $0.28, beats on revenue
2018-03-07T08:00:00-05:00
Your Daily Pharma Scoop: Genocea Surges, Gilead's Biktarvy, GlaxoSmithKline's Vaccine Succeeds In Late-Stage Study
2018-03-05T12:45:39-05:00
Midday Gainers / Losers (3/5/2018)
2018-01-24T08:00:00-05:00
AEterna Zentaris: Licensing Agreement Takes Out Dilution Risk
2018-01-18T10:18:17-05:00
Biotech Forum Daily Digest For January 18th
2018-01-18T08:00:00-05:00
Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD
2018-01-17T12:49:46-05:00
Midday Gainers / Losers (1/17/2018)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
